The potential to differentiate human embryonic stem cells (hESCs) in vitro to provide an unlimited source of human hepatocytes for use in biomedical research, drug discovery and the treatment of liver diseases holds great promise. Here we describe a three-stage process for the efficient and reproducible differentiation of hESCs to hepatocytes by priming hESCs towards definitive endoderm with Activin A and Sodium Butyrate prior to further differentiation to hepatocytes with dimethyl sulfoxide (DMSO) followed by maturation with hepatocyte growth factor (HGF) and oncostatin M. We have demonstrated that differentiation of hESCs in this process recapitulates liver development in vivo: following initial differentiation, hESCs transiently express characteristic markers of the primitive streak mesendoderm before turning to the markers of the definitive endoderm; with further differentiation, expression of hepatocyte progenitor cell markers and mature hepatocytes markers emerged sequentially. Furthermore, we have provided evidence that the hESC-derived hepatocytes are able to carry out a range of hepatocyte functions: storage of glycogen, generation and secretion of plasma proteins. More importantly, the hESC-derived hepatocytes express several members of cytochrome P450 isozymes and these P450 isozymes are capable of converting the substrates to metabolites and respond to the chemical stimulation. Our results have provide evidence that hESCs can be differentiated efficiently in vitro to functional hepatocytes, which maybe useful as a in vitro system for toxicity screening in drug discovery.
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INTRODUCTION
Human embryonic stem cells (hESCs) are able to replicate indefinitely and to differentiate into most, if not all, cell types of the body, thereby having the potential to provide an unlimited source of cells for a variety of applications. These include regenerative medicine for a broad spectrum of human diseases, elucidating mechanisms underlying cell fate specification and as in vitro models for determining the metabolic and toxicological properties of drug compounds [1, 2] . Many of these applications require efficient and regulated differentiation of hESCs to specific cell types. Hepatocytes, the primary cells of the liver, have attracted particular attention as the liver plays a central role in multiple functions of the human body and liver failure is often only treatable by liver transplantation. Unfortunately, the number of donors is insufficient to cope with the growing demand for transplantation. Hepatocyte transplantation, to increase the number of functional hepatocytes, could be employed as an alternative therapeutic approach to whole organ transplantation for liver failure.
Stem cell-derived hepatocytes could also be utilised for extra-corporeal support devices in the case of acute liver failure [3] . In addition to their therapeutic potential, human hepatocytes are valuable for assessing the toxicity of new drugs, as liver is the primary tissue involved in the metabolism of drug compounds and is among the most common tissues affected by drug toxicities. Primary human hepatocytes suffer from not only inconsistent availability but also significant phenotypic and genotypic variability. Although animal models have wide application in preclinical drug development they are often not predictive for man. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   4 Several studies have reported the differentiation of hepatocyte-like cells from human embryonic stem cells [4] [5] [6] . However, these papers have mainly focused on characterizing the final hESC-derived hepatocytes and lack of evidence that hepatocyte differentiation followed the liver developmental process in vivo. The liver, similar to the pancreas, develops from the primitive gut tube which is formed by a flat sheet of cells, called definitive endoderm [5, 7] . Definitive endoderm is one of the three germ layers derived from the epiblast of the inner cell mass of the blastocyst and is generated during the gastrulation stage of embryogenesis. During gastrulation, cells from specific regions of the epiblast are recruited to form the primitive streak where they transform and give rise to both mesoderm and definitive endoderm [8, 9] . The definitive endoderm at the anterior ventral segment of the gut tube interacting with cardiogenic mesoderm becomes more proliferative and forms the liver bud where cells are referred to as hepatoblasts [10, 11] . The hepatoblasts proceed through a series of maturation steps which accompany autonomous proliferation, cellular enlargement and functional maturation as the liver develops. During this process, cells express certain characteristic genes which represent cellular development with the primitive streak and definitive markers at early developmental stages being replaced by hepatic markers at later stages.
After the emergence of the liver bud from the developing gut tube, the level of hepatic maturation is characterized by the expression of liver-and stage-specific genes [12] .
For example, alpha-fetoprotein (AFP) is an early hepatic marker, expressed by hepatoblasts in the liver bud until birth, when expression is dramatically reduced [13] .
In contrast, albumin, the most abundant protein synthesized by hepatocytes, is initially expressed at lower levels in early fetal hepatocytes but this increases as the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   5 hepatocytes mature, reaching a maximum in adult hepatocytes [14] . Furthermore, isoforms of cytochrome P450s (CYPs) proteins also exhibit differential expression levels according to developmental stages of the liver. CYP3A7 is mainly expressed in human fetal liver while CYP3A4 is the predominant isoform in adult hepatocytes [15] .
Previously we developed a method to differentiate hESCs to hepatocyte-like cells [16] .
In the present study, we have improved the procedure further and have significantly increased hepatocyte production from hESCs. We show that by priming hESCs to differentiate through the primitive streak mesendoderm to definitive endoderm prior to treatment with DMSO increases the proportion of hepatocytes in the end population to approximately 70%. Furthermore, we show that the gene expression profile during this differentiation process recapitulates that of in vivo development and the derived hepatocytes performed multiple liver functions.
MATERIALS AND METHODS

Cell culture and differentiation
Human embryonic stem cells H1 and H7 were cultured and propagated in matrigel coated plates with mouse embryonic fibroblast conditioned medium (MEF-CM) supplemented with basic fibroblast growth factor in feeder-free, serum-free conditions as previously described [17] [18] [19] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 6 Sigma) and 100ng/ml activin A (PeproTech)). After 24-48 hours, the medium was changed to priming medium B which is the same as priming medium A, except the concentration of sodium butyrate was reduced to 0.5mM and cells were cultured for a further 48-72 hours. The cells were then split 1:2 to new matrigel coated plates and cultured in differentiation medium (SR/DMSO medium: knockout-DMEM containing 20% serum replacement (SR), 1mM glutamine, 1% non-essential amino acids, 0.1mM -mercaptoethanol (all from Invitrogen) and 1% dimethyl sulfoxide (DMSO, Sigma)), for 7 days. Finally, the cells were cultured in maturation medium (CL15 medium [20]:
L15 medium supplemented with 8.3% fetal bovine serum, 8.3% tryptose phosphate broth, 10µM Hydrocortisone 21-hemisuccinate, 1µM insulin (all from Sigma) and 2mM glutamine) containing 10ng/ml hepatocyte growth factor (HGF) and 20ng/ml oncostatin M (both from R&D systems). The medium was changed daily during differentiation.
RNA isolation and reverse transcription-polymerase chain reaction
Total RNA was isolated using RNeasy mini kit (Qiagen) following manufacturer's instruction and DNA was removed by the treatment with DNase (Qiagen). cDNA was synthesised using 2µg total RNA with reverse transcriptase (Roche) in a 20-25µl volume. PCR was carried out as previously described [21] . Primer sequences and PCR conditions are provided in supplemental data Table 1 .
Immunoblotting, immunocytochemistry and flow cytometry
Cells were lysed and sonicated in sodium dodecyl sulphate (SDS) buffer and the lysates were separated in 8% polyacrylamide gels containing SDS, then transferred to nitrocellulose membrane. Western blotting was carried out as previously described The controls were performed by replacing the primary antibodies with corresponding IgG antibodies and they were negative. The counting on albumin and Hepar 1 staining were done on 300-400 cells in 4 random chosen fields.
Measurement of hepatocyte export proteins
Cells were cultured in 6-well plate in 3ml appropriate media and after 24 hours supernatants were collected for export protein assay. The hepatic export proteins alpha-2-macroglobulin (A2M), haptoglobin, fibrinogen and fibronectin were measured using sandwich enzyme-linked immunosorbent assays (ELISA) essentially as described by the manufacturer (DAKO, Ely, UK). High binding EIA plates (Corning, Koolhovenlann, Netherlands) were coated with rabbit anti-human antibody (DAKO, Ely, UK) to each specific protein overnight at 4°C. Antibodies were diluted 1:1000 for A2M and fibronectin, 1:2000 for haptoglobin and 1:10000 for fibrinogen.
Sample supernatants were diluted 1:10 and then added to 96-well plate in triplicates.
The plates were incubated for 2 hours at room temperature. Peroxidase-conjugated rabbit anti-human antibody (DAKO) directed against the appropriate protein was added and the plates were incubated for 1 hour at room temperature. The substrate ophenylenediamine (OPD) was added and the reaction stopped with 0.5M sulphuric acid. The plates were read at 490 nm with a reference wavelength of 630nm using a MRX II plate reader (Dynatech, Billinghurst, UK) and the concentration of the appropriate protein in each sample was calculated from standard curves using the MRX II Endpoint software. Analysis of significance between variables was performed using the paired two-tailed t-test. A difference was considered significant using 95% confidence intervals (P<0.05).
Measurement of basal metabolism
hESC-derived hepatocytes and HepG2 cells (ECACC no 85011430) were incubated with a cocktail of midazolam, bufuralol, phenacetin and tolbutamide, each at a final concentration of 10µM except tolbutamide which was at 100µM in the culture medium. After 24 hours, medium was collected and treated with acetonitrile to prevent further enzyme activity. The concentration of the metabolites, 1'-hydroxymidazolam, 1'-hydroxybufuralol, acetaminophen and 4'hydroxytolbutamide, were measured using reverse phase HPLC with tandem mass spectrometric detection (LC-MS/MS) and the amounts were calculated according to the standards which were prepared 0-500ng/ml in the same culture medium. All the P450 substrates and metabolites were obtained from Ultrafine Chemicals or Sigma-Aldrich. The metabolites were normalised over alanine aminotransferase (ALT) activity which was measured from cell lysates using a Cobas Integra 400 clinical analyzer (Roche) and an in vitro diagnostic reagent system for ALT. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
RESULTS
Directed hepatocyte differentiation from hESCs
We have developed a three-step protocol by modifying our previous method [16] to maximize hepatocyte production from hESCs ( Fig.1A and Methods). In this protocol, hESCs, routinely cultured without feeder cells as described previously [18] , were first treated with 100ng/ml activin A and 1 mM NaB for 24-48 hours, followed by 2-3 days of 100ng/ml activin A and 0.5 mM NaB. During the first 24-hour period, we observed dramatic cell death, the surviving cells proliferated well, reaching about 70% confluence by the end of the priming stage (Fig.1A) . The cells were then split at a 1:2 ratio and cultured in unconditioned ES medium supplemented with 1% DMSO for 7 days. The cells gradually exhibited morphological change from a spiky shape to a polygonal outline (Fig. 1B) . Finally, the medium was changed to modified L15 medium (see Methods for details) supplemented with 10ng/ml hepatocyte growth factor (HGF) and 20ng/ml oncostatin M (OSM) for a further 7 days. During the differentiation process, the hESCs went through a series of profound morphological 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 changes and hepatocyte morphology started emerging from day 9. By day 13, the cells revealed characteristic hepatocyte morphology: polygonal in shape and distinct round nuclei ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 differences between RT-PCR and western blot on HNF4 and albumin mainly reflect sensitivity difference between the two techniques.
Immunostaining further confirmed the specificity of gene expression. During stage 1 differentiation, CXCR4 expressing cells increased significantly from less than 15% before differentiation to over 70% at end of stage 1, which is similar as reported (Fig.   2D ) [26] . The transcription factors FoxA2 and HNF4 were localised in the nuclei, and AFP, albumin, and hepar1 showed cytoplasmic staining (Fig. 3A) . The hESCderived hepatocytes were also stained positive for aminopeptidase N (CD13) which has been reported to be positive for canaculi [27] . When stained with cytokeratin antibodies, CK18 and CK19, most of the hESC-derived hepatocytes were positive (Fig. 3B) .
Activin A and sodium butyrate co-operate to increase hepatocyte production from hESCs
In our previous method, we applied the SR/DMSO directly on hESCs to induce 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   13 contribute to more homogeneous hepatocyte differentiation [4] and more recently, NaB and activin A together are found to induce definitive endoderm differentiation from hESCs [31] . In order to further investigate the role of activin A and NaB in the definitive endoderm differentiation, the hESCs (both H7 and H1) were treated with activin A or NaB alone or with both. After the first 24 hours of treatment, the later two conditions displayed substantial levels of cell death. Therefore, the NaB was reduced to 0.5mM for a further two days before replaced by DMSO containing medium. At this point, the cells from all of these treatments displayed similar morphologies. However, after 4 days culture in DMSO containing medium, the cells exhibited different changes in morphology. A considerable number of the cells in activin/NaB combined treatment had revealed early hepatocyte morphology, while cells treated with activin alone resulted in less hepatocyte formation and no clear hepatocyte differentiation was observed in NaB treatment (Fig. 4A ).
The profile of gene expression was analysed throughout the first three days and was very similar between the combined and activin alone treatments, but different from NaB treatment (Fig. 4B) . The former showed primitive streak and definitive endoderm markers expression, such as mixL1 GSC, Sox17 and FoxA2, which are very low or absent in NaB alone treated cells. However, the undifferentiation marker gene nanog had obvious higher expression in activin alone treated cells than those treated with combined activin and NaB, indicating that in the current conditions activin alone treatment for 3 days contained more undifferentiated cells which may result in more heterogeneous population after further differentiation with DMSO. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   14 To test the functionality of hESC-derived hepatocytes, we carried out several experiments. One of the functions of the liver is its production and export of plasma proteins which are important in maintaining homeostasis of the body. In addition to albumin, other proteins include fibrinogen, a zymogen of fibrin which is important for blood clotting function; fibronectin, an important extracellular protein capable of binding receptor proteins, and alpha-2 macroglobulin (A2M), a multifunctional binding protein. To examine if the hESC-derived hepatocytes were capable of synthesizing and releasing these proteins into the culture medium, we measured these proteins in the culture medium by enzyme-linked immnosorbent assay (ELISA) during the stage 3 when early hepatocytes had formed. The data clearly show that these export proteins were significantly increased in the culture medium in comparison with hESC controls and the production of these proteins peaked at the later stages of the differentiation protocol when the hESC-derived hepatocytes were more mature (Fig. 5A) .
Liver function in hESC-derived hepatocytes
Another important function of liver is metabolism and detoxification, in which P450 cytochrome enzymes (CYPs) play a critical role. Thus, we examined expression of several members of this multigene family, including CYP3A4, CYP3A7, CYP2D6, CYP2C9 and CYP2C19 in the hESC-derived hepatocytes either by RT-PCR or western blotting. The western blotting results showed a marked increase in the expression of CYP3A and CYP2D6 proteins after hESCs were differentiated to hepatocytes (Fig. 6A) . The CYP3A expression was also detected by immunostaining (Fig. 5B) . The RT-PCR showed that both CYP3A4 and CYP3A7 were expressed in hESC-derived hepatocytes and the specificity and fidelity of CYP3A4 and CYP3A7 PCR products was confirmed by sequencing (Fig. 6B) . The expression levels of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 15 CYP3A4 in the hESC-derived hepatocytes was similar to that observed in fetal liver tissues but lower than in adult liver and the CYP3A7 expression was lower than in fetal tissues. We also detected CYP2C9 and CYP2C19 expression in the hESCderived hepatocytes though the levels were lower than in adult liver tissues. In addition to the P450 isozymes, the expression of the cytochrome P450 reductase 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 significant proportion of currently used drugs [33] . Since the human form of CYP3A4 can be induced with rifampicin through the transcription factor PXR, we treated both hESC-derived hepatocytes and HepG2 cells with rifampicin for 72 hours followed by treatment with CYP3A4 substrate, midazolam, and the formation of 1'hydroxymidazolam was measured by mass spectrometry. hESC-derived hepatocytes produced higher levels of metabolites in response to rifampicin treatment although the increase was less than 2 fold (Fig. 6D) . This suggests that the hESC-derived hepatocytes do respond to chemical treatment and that PXR is active in these cells.
We also examined the glycogen storage function in the hESC-derived hepatocytes using Periodic Acid Schiff (PAS) staining. In compare with fibroblast (Suppl. Fig.   7B ), the hESC-derived hepatocytes exhibited evident glycogen storage (Fig.5B ).
DISCUSSION
We have developed a new differentiation protocol based on our previous one for efficient differentiation of hepatocytes from human ES cells. Direct comparison of the two protocols showed that activin priming protocol exhibited significant increase in the number of hepatocyte-like cells (70%) in compare with the previous protocol (10%) though hepatocytes derived from both protocols showed similar gene expression pattern (Fig. 2 and [16] ). However, due to the low efficiency, we were unable to carry more detailed analysis on previous differentiation as we had to dissect hepatocyte foci for RT-PCR. With current protocol, we were able to extract RNA and protein from whole cell population and performed gene expression analysis during the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 In addition, by the end of stage 3, the hESC-derived hepatocytes also expressed NADPH-cytochrome P450 oxidoreductase (CPR), several cytochrome P450s and pregnane X receptor (PXR). Moreover, not only are the P450 enzymes expressed but also they could convert substrates to metabolites more efficiently than HepG2 cells. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 important implications for the application of hESC-derived hepatocytes as an in vitro model for drug development. Since it is very difficult to obtain human liver tissues, we were unable to directly compare our hESC-derived hepatocytes to primary human hepatocytes on the functionality tests. However, from the gene expression analysis, we think that to be able to use hESC-derived hepatocytes for drug screening, further improvement may be required, particularly on maturation. The current protocol has significantly improved differentiation efficiency but the hESC-derived hepatocytes 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 In our differentiation protocol, the combination of activin A and NaB treatment primes hESCs more efficiently after further differentiation to hepatocytes than the activin A alone. However, when we checked the gene expression patterns after stage 1 in both H1 and H7 cells, the activin A only treated group seemed to have higher expression of the definitive endoderm markers (e.g. Sox17, FoxA2) and NaB itself did not show any evidence of promoting hESCs to the definitive endoderm. This raises the question of the role of NaB in this process. NaB, a short-chain fatty acid, is a histone deacetylase (HDAC) inhibitor and has been reported to induce growth arrest, differentiation and apoptosis in a number of cancer cells [36, 37] . Since NaB and the combined treatment resulted in more cell death than activin A alone in our experiments, we hypothesised that NaB functions as a selecting reagent to ablate 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   20 hepatocytes. This system will be very useful in the further development of using hESC-derived hepatocytes for biomedical and clinical research and application.
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